Spatial Chromatin Accessibility Analysis of Intratumor Heterogeneity in Breast Cancer

Read full text
Authors: Yingying Qian, Miao Zhu, Chongyang Ren, Yeyong Zhou, Jian Xu, Liang Dong, Guangyu Zhang, Guangyu Zhang, Jiaoyi Lv, Jiaoyi Lv, Qiaorui Xing, 张国淳
+3 more 张国淳, Guangdun Peng, Ning Liao
Cited by: 2
References: 1

Abstract

Intratumoral heterogeneity (ITH) is a major driver of mortality in breast cancer (BC) patients and a critical factor in the variable therapeutic outcomes observed in BC treatment. Understanding the mechanisms underlying ITH is essential for advancing both clinical and basic BC research. Chromatin accessibility is critical for the regulation of gene expression and cellular identity and plays a central role in shaping ITH and tumor evolution. However, studying chromatin accessibility in situ has been challenging due to the limited availability of technical platforms. Here, we leveraged the spatial assay for transposase-accessible chromatin sequencing (ATAC-seq) platform to profile the chromatin accessibility landscape of tumors from six BC patients. Our analyses revealed prominent heterogeneity within tumor regulatory modules and spatial variations in immune cell composition and stromal structures, offering a framework for the investigation of the molecular architecture underlying ITH. Moreover, we identified two tumor subclones with a potential common origin but distinct immune infiltration conferred by regulatory cascades, suggesting that epigenetic regulation may further contribute to the divergent tumor microenvironments and phenotypic diversity of these subclones. Our study provides novel insights into the molecular mechanisms driving ITH and opens up potential avenues for therapeutic intervention.

Fields of Study & Subjects

Cancer Genomics and Diagnostics Chromatin Remodeling and Cancer Single-cell and spatial transcriptomics

Publication details

Journal / source
Genomics Proteomics & Bioinformatics
Publisher
Oxford University Press (OUP)
Volume
24
Issue
1
Publication date
1 January 2026
Language
EN